0
The Pediatric Forum |

Growth Attenuation: Unjustifiable Non-therapy

Hank Bersani, PhD
[+] Author Affiliations

Copyright 2007 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
Arch Pediatr Adolesc Med. 2007;161(5):520-522. doi:10.1001/archpedi.161.5.520-b
Text Size: A A A
Published online

Gunther and Diekema1 provided the case of a 6-year-old girl with profound and multiple impairments who underwent a hysterectomy and “growth-attenuation therapy.” The intention was to avoid a future out-of-home placement by ensuring that the child remained small in stature, thereby helping her parents to continue to care for her. As leaders of the American Association on Mental Retardation, the oldest multidisciplinary association in the United States representing professionals within the field of intellectual and developmental disabilities, we endorse policies and actions that help families to rear their children at home, and we applaud the efforts of the many professionals who provide extraordinary care to children with intensive and pervasive support needs. However, we view growth-attenuation as a totally unacceptable option. Brosco and Feudtner2 raised serous concerns, and we add to those.

Gunther and Diekema recognized little potential for the growth and development of this child. However, there is abundant evidence that all children are able to learn, that the cognitive capabilities of children with severe motor impairments can be grossly underestimated, and that an ever-improving future for individuals with extensive impairments is achievable.

Estrogen has hugely important actions throughout development, and the long-term consequences of this extreme intervention may be deleterious. Further, the suggestion that growth attenuation should not be a concern if we truly accept the position of disability advocates (that physical stature is irrelevant) distorts logic. There is nothing in the disabilities rights movement that could possibly justify constraining anyone's development.

Most importantly, we do not see growth attenuation as therapy at all. Therapy addresses a condition of a patient; it does not impede normal development. The parallel with abandoned practices that targeted tall young women seems desperate, but even there assent was obtained. Clearly, this child had her body altered irreversibly without her awareness. While parents are rightly vested with the responsibility for making health care decisions for their minor children, their prerogatives are not absolute. Children have their own distinct rights and protections. In these types of situations, both law and ethics demand that these rights be protected, and an independent professional with expertise in disability rights must be formally involved.

There is an enormous potential for abuse here. Practice can rapidly degenerate if the anxieties of the parents replace the medical status of the child as the immediate focus. What would argue against restricted caloric intake to minimize weight or even “amputation therapy”? Given the history of neglect and devaluation of this population, we are appalled that anything like this could, in 2006, still be a topic for serious debate.

AUTHOR INFORMATION

Correspondence: Dr Bersani, President, Board of Directors, The American Association on Mental Retardation, Western Oregon University, 345 N Monmouth Ave, Monmouth, OR 97381 (bersanh@wou.edu).

Financial Disclosure: None reported.

Gunther  DF, Diekema  DS. Attenuating growth in children with profound developmental disability: a new approach to an old dilemma. Arch Pediatr Adolesc Med 2006;1601013- 1017
PubMed
Brosco  JP, Feudtner  C. Growth attenuation: a diminutive solution to a daunting problem. Arch Pediatr Adolesc Med 2006;1601077- 1078
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Gunther  DF, Diekema  DS. Attenuating growth in children with profound developmental disability: a new approach to an old dilemma. Arch Pediatr Adolesc Med 2006;1601013- 1017
PubMed
Brosco  JP, Feudtner  C. Growth attenuation: a diminutive solution to a daunting problem. Arch Pediatr Adolesc Med 2006;1601077- 1078
PubMed

Correspondence

May 1, 2007
Daniel F. Gunther, MD, MA; Douglas S. Diekema, MD, MPH
Arch Pediatr Adolesc Med. 2007;161(5):520-522.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 5

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles